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The intercellular adhesion molecule-5 (ICAM-5) regulates neurite outgrowth and synaptic
maturation. ICAM-5 overexpression in the hippocampal neurons induces filopodia
formation in vitro. Since microglia are known to prune supernumerous synapses during
development, we characterized the regulatory effect of ICAM-5 on microglia. ICAM-5
was released as a soluble protein from N-methyl-D-aspartic acid (NMDA)-treated
neurons and bound by microglia. ICAM-5 promoted down-regulation of adhesion and
phagocytosis in vitro. Microglia formed large cell clusters on ICAM-5-coated surfaces
whereas they adhered and spread on the related molecule ICAM-1. ICAM-5 further
reduced the secretion of the proinflammatory cytokines tumor necrosis factor α (TNF-α)
and interleukin 1β (IL-1β), but on the contrary induced the secretion of the anti-
inflammatory IL-10 from lipopolysaccharide (LPS) stimulated microglia. Thus, ICAM-5
might be involved in the regulation of microglia in both health and disease, playing an
important neuroprotective role when the brain is under immune challenges and as a
“don’t-eat-me” signal when it is solubilized from active synapses.
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INTRODUCTION
The intercellular adhesion molecule-5 (ICAM-5), also known as telencephalin, is a membrane-
spanning adhesion molecule that regulates neuronal development is several ways (Tian et al.,
2000b, 2007; Matsuno et al., 2006; Gahmberg et al., 2014). ICAM-5 is expressed on the
dendrites and soma of neurons of the telencephalon, with the highest level of expression in the
glutamatergic neurons of the hippocampus and cerebral cortex. The extracellular part contains
nine immunoglobulin domains that bind several ligands (Yoshihara et al., 1994; Tian et al.,
1997; Zhang et al., 2008; Furutani et al., 2012; Recacha et al., 2014). During the initial contact
between the pre- and the postsynaptic terminals, ICAM-5 binds β1 integrins on the presynaptic
element and stabilizes the contact sites (Ning et al., 2013). As the spines mature, ICAM-5 migrates
away from the postsynaptic density to the spine shafts. During early development, ICAM-5
induces neurite sprouting, supposedly through homophilic binding (Tian et al., 2000b). On mature
dendrites, ICAM-5 promotes filopodia formation, but subsequently retards spine maturation
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(Matsuno et al., 2006). ICAM-5 inhibits the maturation process,
but under regulated conditions maturation must be granted.
In the glutamatergic synapses where ICAM-5 is expressed,
N-methyl-D-aspartic acid (NMDA) receptor signaling removes
the ICAM-5 block. This leads to shedding of the extracellular
part of ICAM-5 (Tian et al., 2007). ICAM-5 is cleaved by matrix
metalloproteinases (MMP), mainly MMP-2 and -9, generating
two major soluble fragments around 100 kDa (Tian et al.,
2007; Conant et al., 2010). Once the ectodomain is cleaved,
the cytoplasmic tail is released from the actin-linking protein
α-actinin. The interaction with α-actinin is important for
neurite sprouting and elongation and spine maturation (Nyman-
Huttunen et al., 2006; Ning et al., 2015).
Microglia express integrins that have been shown to bind
ICAM-5 in other cells (Akiyama and McGeer, 1990). The α5β1
integrin [very late antigen-5, (VLA-5)] on neurons and the αLβ2
[leukocyte function associated antigen-1 (LFA-1)] on leukocytes
have been demonstrated to act as receptors for ICAM-5 (Tian
et al., 1997; Ning et al., 2013). Our laboratory has previously
shown that ICAM-5 has an immunosuppressive effect on T cells
(Tian et al., 2008).
Microglia are macrophage-like cells in the brain that
respond to brain injury by secreting proinflammatory
cytokines. Inflammation is associated with most traumatic,
neurodegenerative and neurodevelopmental disorders, where
microglia are key players. At the resolving phase of the injury,
microglia adopt a neuroprotective phenotype and the cytokine
profile shifts toward anti-inflammatory. Cytokines considered
as proinflammatory are for example IL-1, IL-6, TNF-α, and
interferon-γ. Classical components of the anti-inflammatory
cytokine profile are IL-4, IL-10 and transforming growth
factor-β (Smith et al., 2012). Although microglia are the resident
immune cells of the brain, they have been shown to contribute
to much more than immune functions in the central nervous
system. They can regulate synaptic plasticity, prune synaptic
structures, provide neuronal guidance and secrete neurotrophic
factors (Paolicelli et al., 2011; Hong et al., 2016). Microglia can
make direct contact with both pre- and postsynaptic elements
and modulate the collapse or maturation of synapses (Wake
et al., 2009; Miyamoto et al., 2016). These phagocytic cells
remove excess synapses through a process that is regulated by
components of the complement cascade (Stevens et al., 2007;
Schafer et al., 2012). If ICAM-5 is bound to microglia, it could
potentially regulate several aspects of the above-mentioned
microglia functions. Both ICAM-5 and microglia play a role
in immunological and neuroplastic events. Therefore, we have
now studied the effect of ICAM-5 on microglia and gained
novel insights into the regulatory effect that neurons have on
microglia.
MATERIALS AND METHODS
Reagents and Antibodies
The polyclonal rabbit antibody 1000J [1:1000 in western blot
(WB) or immunofluorescence (IF)] and monoclonal mouse 246H
(1:2000 in WB) and 179D [1 µg in immunoprecipitation (IP)]
against immunoglobulin (Ig)-like domains 1–2 (D1-2) of ICAM-
5 were kind gifts from P. Kilgannon (ICOS corporation, Seattle,
WA, United States) (Tian et al., 2000a; Ning et al., 2013). Integrin
β1 monoclonal antibody TS2/16 was a kind gift from Dr. T. A.
Springer (Harvard Medical School, Boston, MA, United States),
1:500 in WB (Ning et al., 2013).
The following antibodies were purchased: integrin β2 (10E12,
ab86457, Abcam, Cambridge, United Kingdom, 1:200 in IF
and 1:1000 in WB), integrin β1 (ab52971, Abcam, 1:150 in
IF, 1 µg in IP), Iba1 (Wako, Japan, 1:100 in IF), β-actin
(5060, Sigma–Aldrich, St. Louis, MO, United States, 1:2000 in
WB), mouse IgG (Mi4 ms IgG1, Merck Millipore, Burlington,
MA, United States, 1 µg in IP), ICAM-1 function blocking
antibody (LEAFTM purified anti-mouse CD54, YN1/1.7.4,
BioLegend, San Diego, CA, United States) and the isotype
control (LEAFTM purified rat IgG2bκ, RTK4530, BioLegend).
Horseradish peroxidase (HRP)-conjugated secondary antibodies
(Cell Signaling Technology, Danvers, MA, United States, 1:3000)
were used for WB. For the IF, we used Alexa Fluor 488-,
Alexa Fluor 633- (Molecular Probes, Thermo Fisher Scientific,
Waltham, MA, United States, 1:300) and cy3-conjugated (Jackson
ImmunoResearch, West Grove, PA, United States, 1:300)
secondary antibodies, Alexa Fluor 633-conjugated phalloidin
(1:100), and 4′,6-Diamidine-2′-phenylindole dihydrochloride
(DAPI, 1:10 000, Molecular Probes).
The human ICAM-5 D1-2-Fc E37A mutation was cloned
using site-directed mutagenesis (Figures 1A,B; Artimo et al.,
2012). The ICAM-5-Fc D1-2 and D1-2 E37A were prepared
as previously described (Tian et al., 1997; Ning et al., 2013).
One additional step was added to the purification protocol.
The isolated proteins were run through a PierceTM High
Capacity Endotoxin Removal Spin Column (Thermo Fisher
Scientific). Recombinant mouse ICAM-5 D1-9-Fc chimeric
protein, recombinant mouse ICAM-2-Fc chimeric protein,
recombinant mouse ICAM-1 D1-5-Fc chimeric protein and
recombinant mouse vascular cell adhesion molecule, VCAM-
1-Fc chimeric protein were purchased from R&D Systems
(Minneapolis, MN, United States). Human fibrinogen was
purchased from Calbiochem (San Diego, CA, United States).
Fibronectin was isolated from human plasma using gelatin
agarose (Vuento and Vaheri, 1979). Recombinant purified
human complement factor iC3b was purchased from Merck
Millipore. Human IgG1 as a negative control was purchased from
Sigma–Aldrich.
Other materials include phagocytosis beads (FluoresbriteTM
carboxy YG 2.0 µm Microspheres) from Polysciences, Inc.
(Warrington, PA, United States), and protein A-coated
polystyrene beads (SPHEROTM, 4.37 µm diameter) from
Spherotech Inc. (Lake Forest, IL, United States).
Animals and Cell Culture
Wild-type (WT) and ICAM-5 knock-out (KO) C57BL/6jOla
mice were used in this study. The ICAM-5 KO mice were
generated as complete knock-outs by gene targeting (Nakamura
et al., 2001). The animals were housed at the animal facility
of the University of Helsinki with 12 h light cycle and
12 h dark cycle, food and water ad libitum. All the animal
Frontiers in Molecular Neuroscience | www.frontiersin.org 2 December 2017 | Volume 10 | Article 431
fnmol-10-00431 December 22, 2017 Time: 9:41 # 3
Paetau et al. Neuronal ICAM-5 Regulates Microglia Functions
FIGURE 1 | Partial sequences and purified proteins used in this study. Intercellular adhesion molecule-5 (ICAM-5) shows a high homology between species. The
Ig-like domains 1–2, D1-2, that bind integrins are 90.2% identical in mice and humans. (A) The Ig domains are marked by D1 and D2, and the mutated glutamate is
boxed and marked by E37A. An overview of the recombinant ICAM-5 proteins, all fused to the human Fc-tag, used in this study are illustrated in B. The E37A
mutation site is indicated by a black arrow.
experiments were performed under the internal license of the
University of Helsinki. Primary neuronal cultures were prepared
as described (Nyman-Huttunen et al., 2006) and maintained
in full Neurobasal medium (Gibco, Thermo Fisher Scientific)
supplemented with 1% L-glutamine (Lonza, Basel, Switzerland)
and 1x B-27 supplement (Gibco). Primary microglia cultures
were prepared as described (Maciejewski-Lenoir et al., 1999).
Briefly, P3-6 brains were stripped of meninges and cortical
single cell suspensions were prepared. The mixed glia were
cultured in poly-L-lysine (PLL, Sigma–Aldrich) pre-coated T-
75 (Sigma–Aldrich) flasks until confluent, after which microglia
were isolated by orbital shaking. This produced a > 95% pure
microglia culture. BV-2 is a murine microglia cell line that
was a kind gift from Heikki Rauvala, University of Helsinki.
BV-2 cells were maintained in the same conditions as primary
microglia in full Dulbecco’s modified eagle medium (DMEM,
Gibco), 10% fetal bovine serum (FBS, Gibco), 1% penicillin-
streptomycin (PS, Lonza) and 1% L-glutamine (Lonza), at+37◦C
and 5% CO2.
Neuron-Conditioned Medium
At 14–21 days in vitro (DIV) cortical neuron cultures were
treated for 6 h with Hank’s balanced salt solution (HBSS, Gibco)
containing 1.8 mM CaCl2, with or without 20 µM NMDA
(Sigma–Aldrich), with or without 20 µM GM6001 (Calbiochem).
Prior to stimulation, the cell cultures were washed once with
HBSS. The conditioned medium was filtered (0.22 µm pore size,
Sartorius, Göttingen, Germany), aliquoted and frozen, unless
used immediately. Normal neuron-conditioned culture medium
was also used in this study. At 21 DIV, the culture medium
(full Neurobasal) that had been conditioned for 3–4 days on
the neurons was collected and treated as above. The neuron-
conditioned medium was used to treat microglia or BV-2 cells for
1 h in the cell culture incubator.
Fixation, Cleared Lysates and Brain
Homogenates
After treatments, the cells were washed in phosphate buffered
saline (PBS, Lonza) and either lysed or fixed. Cleared lysates
were prepared by incubating the cells in 2% RIPA buffer
(150 mM NaCl, 50 mM Tris, 10 mM MgCl2, 5 mM EDTA, 1%
Triton X-100, 1% NP-40, pH 7.8) supplemented with fresh 1×
protease inhibitor cocktail (Roche, Basel, Switzerland) and 1×
phosphatase inhibitor (Roche) for 20 min on ice. Lysates were
cleared to cell free extracts (CFE) by centrifugation at 16000 g
for 20 min at +4◦C. Alternatively, cells were fixed for 20 min at
ambient temperature in 4% paraformaldehyde (PFA, J.T. Baker
Inc., Center Valley, PA, United States) in PBS, then washed
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and stored in PBS at +4◦C. The cortices of adult WT mice
were homogenized in 2% RIPA buffer using a plastic pestle. The
homogenates were cleared the same way as the lysates. The total
protein concentration was measured by the Pierce BCA protein
assay kit (Thermo Fisher Scientific) and 400 µg of total protein
was used for IP.
Adhesion Assays
RTCA iCELLigence
iCELLigenceTM (ACEA Biosciences, Inc., San Diego, CA,
United States) is an instrument that measures electrical
impedance at the bottom of a cell culture well containing
microelectrodes (e-plate). The wells of the e-plate were coated
with recombinant protein at 100 nM in PBS overnight at +4◦C.
The wells were washed with PBS and equilibrated in the cell
culture incubator together with the instrument. An equilibration
sweep was done followed by the addition of 20000 cells in full
DMEM to each well. The experiment was started immediately
with one sweep/min for the total of 6 h. The data were analyzed
with the iCELLigence software and in Microsoft Excel where all
individual samples were set to start from the cell index zero. The
cell index is a measure of impedance recorded by the instrument.
The higher the value the more spread are the cells on the bottom
of the well.
Static Adhesion Assay
Acid-base-washed cover slips, 8-chamber slides (Thermo Fisher
ScientificTM NuncTM Lab-TekTM II Chamber SlideTM System)
or the wells of a 96-well flat-bottom microtiter plate (Greiner,
Sigma–Aldrich) were coated with recombinant protein at 100 nM
in PBS for 1 h at ambient temperature or overnight at
+4◦C. The plate was equilibrated in the cell culture incubator
prior to washing with PBS and the addition of cells. BV-
2 cells or primary microglia (10000 cells per well) were re-
suspended in pre-warmed, full DMEM medium and allowed
to interact with the substrate for 24 h in the cell culture
incubator. The cells were imaged, then the culture medium
was collected and cells were washed three times in PBS
and fixed. ICAM-1 blocking antibody or isotype control was
also added to cells cultured on ICAM-5 coated surface at
10 µg/ml.
To investigate the effect of soluble ICAM-5 on BV-2 adhesion
to iC3b, flat-bottom 96-well microtiter plates were coated with
iC3b (8 µg/ml in PBS) overnight at +4◦C. The wells were
washed three times with PBS and blocked with 1% heat-
denatured (15 min at +80◦C) bovine serum albumin (BSA,
R&D Systems) for 1 h. Static adhesion was performed in warm
HBSS buffer containing 15 mM HEPES, 5 mg/ml glucose and
1 mM sodium glutamate. The cells were pre-incubated for
10 min with 100 nM of recombinant protein, and then added
to the iC3b-coated wells at the density of 120000 per well and
incubated for 30 min in the cell culture incubator. Unbound
cells were removed by washing twice in PBS and the adhered
cells were quantified by using alkaline phosphatase assay. Briefly,
p-nitrophenyl phosphate substrate tablets (Sigma–Aldrich) were
dissolved in the buffer containing 50 mM NaCH3COO, pH
5, and 1% Triton X-100 at a concentration of 3 mg/ml, and
100 µl of substrate solution was added to each well. The cells
were lysed for 45 min at +37◦C. The reaction was stopped with
1 M NaOH and the optical density at 405 nm was measured
(Multiskan GO Microplate Spectrophotometer, Thermo Fisher
Scientific).
Ligand Coated Bead Adhesion
Protein A-coated beads were coupled to ICAM-5-Fc D1-9, D1-2-
Fc, D1-2 E37A-Fc or ICAM-1-Fc. One microgram of protein per
10µl bead slurry was allowed to couple for 1 h at+4◦C. Unbound
proteins were washed away once with PBS. Primary microglia or
BV-2 cells cultured in 24-well plates were washed once in PBS,
and the 10 µl of coated bead slurry in 300 µl PBS was added. Cells
were allowed to bind beads for 1 h in the cell culture incubator.
The unbound beads were then rigorously washed away with PBS
and the cells were fixed and stained with phalloidin, and anti- β1-
and β2-integrin antibodies.
Pull-Down Assay
BV-2 cells were cultured until approximately 80% confluent
in 10 cm culture plates. Lysates were prepared and the
corresponding amount of one plate was used per sample. One
microgram recombinant protein was coupled to 20 µl protein
G slurry (GE Healthcare, Little Chalfont, United Kingdom) and
washed in PBS. The CFEs that had been combined for pre-
clearing were divided over the tubes containing the coupled
sepharose. After a 2 h incubation at +4◦C with end-over-end
rotation, the sepharose was washed twice in 2% RIPA buffer and
then once in PBS. The protein complexes were eluted by boiling
for 5 min in Laemmli sample buffer. The samples were then
subjected to WB analysis.
Immunoprecipitation
BV-2 cells treated for 1 h with neuron-conditioned medium were
lysed and the pooled CFE was pre-cleared. The corresponding
volume of CFE from one 10 cm culture plate (1 ml) was incubated
for 2 h at +4◦C with 1 µg of one of the capture antibodies.
Twenty microliter of protein G slurry was added to each sample
that were then incubated for 1 h at +4◦C. Alternatively, 400 µg
total protein of adult WT cortical homogenates were used for
IP using 179D as capture antibody. The sepharose samples were
washed twice in 2% RIPA buffer and once in PBS. The antibody
complexes were then eluted by boiling for 5 min in Laemmli
sample buffer. The samples were further analyzed by WB.
Western Blots
Samples were separated by SDS–PAGE in a NuPAGETM 4–
12% Bis-Tris Protein Gel, 1.0 mm, 10-well (Thermo Fisher
Scientific) and transferred to nitrocellulose (GE Healthcare)
or polyvinylidene difluoride (PVDF, Thermo Fisher Scientific)
membranes. Precision Plus ProteinTM Pre-stained All Blue
standard (Bio-Rad, Hercules, CA, United States) was used.
The membranes were then blocked in 5% skimmed milk,
followed by primary antibody in 3% skimmed milk for
2 h at ambient temperature or overnight at +4◦C, then
after washing, incubated for 1 h at ambient temperature
with secondary HRP-conjugated antibody. After the final
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washing steps, the membranes were incubated in Clarity ECL
substrate (Bio-Rad) and used to expose x-ray films (Fuji
film, Tokyo, Japan). The band intensities were analyzed using
Fiji (NIH).
Immunofluorescence Staining
Fixed cells were permeabilized with PBS containing 0.1%
saponin (Sigma–Aldrich) for 5 min. They were then blocked
with PBS containing 0.05% saponin and 5% BSA for 2 h at
ambient temperature or overnight at +4◦C. Antibodies were
diluted in PBS with 3% BSA and 0.05% saponin. Primary
antibody incubation was for 2 h at ambient temperature or
overnight at +4◦C. Secondary antibody incubation was carried
out for 1 h at ambient temperature. Washing steps following
antibody incubations were three times for 10 min with PBS
containing 0.05% saponin. Cover slips were finally mounted
with ProLong gold or diamond antifade reagent (Thermo Fisher
Scientific).
Phagocytosis Assay
The phagocytic capacity of microglia was investigated in cultured
microglia. Isolated microglia were cultured for 3–5 days on
PLL-coated glass cover slips or non-coated cell culture plastic.
Phagocytosis beads were mixed 1:100 in full DMEM containing
100 nM of protein. The cells were incubated for 1 h with the beads
and the protein in the cell culture incubator. The cultures were
thoroughly washed with PBS prior to fixation.
ELISA Assay
The mouse TNF-α, CCL5, IL-1β and IL-10 DuoSet ELISA
were purchased from R&D Systems. Culture medium from
microglia treated for 24 h with DMEM supplemented with
5% FBS, 1% L-glutamine, 10 ng/ml LPS (Sigma–Aldrich) and
either ICAM-5 D1-9 or D1-2, ICAM-1, IgG or only PBS, was
collected and centrifuged to remove cellular debris and stored at
−80◦C until further use. Hundred microliter of the medium was
analyzed for cytokine production in duplicates according to the
manufacturer’s instructions. The optical density at 450 nm was
measured.
Imaging and Data Analysis
Cells were imaged with the confocal microscope Leica TCS
SP5 fitted with the HCX APO 63×/1.30 Corr (glycerol)
CS 21objective or Evos inverted microscope (Thermo Fisher
Scientific). Where applicable, experiments were run in at least
duplicates and repeated at least three times with similar results.
Micrographs were collected at least 10 frames per sample. The
data set was blinded and analyzed. The data are represented as
normalized between experiments or single experiments where
repetitions show similar results.
Images were analyzed using Fiji (NIH). For co-localization
studies, confocal images were automatically analyzed and
individual cells were manually selected as region of interest.
The data were analyzed using JASP software. The data are
shown as mean values with standard deviation as error bars.
Statistical significance was investigated by non-paired Student’s
t-test or one-way ANOVA, followed by Bonferroni’s post hoc test
(∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001).
RESULTS
Endogenous ICAM-5 from Neurons Is
Bound by Microglia
The intercellular adhesion molecule-5 is solubilized by strong
synaptic activity. To investigate the biological activity of the
soluble ICAM-5, we studied the effect on microglia. Microglia
are involved in pruning and the most active time for pruning
happens to coincide with a rapid increase in ICAM-5 expression
in the mammalian brain (Yoshihara and Mori, 1994). First, we
wanted to verify that endogenous soluble ICAM-5 released from
neurons could be bound by microglia. For this purpose, we
prepared neuron-conditioned medium from WT and ICAM-5
KO cortical neuronal cultures. As illustrated in Figure 2A,
cultured neurons constitutively shed ICAM-5 into the culture
medium. This effect was dramatically enhanced by NMDA
treatment of the cells and the general MMP inhibitor, GM6001,
completely abrogated the release of ICAM-5, as has been shown
previously (Tian et al., 2007). Microglial cells that had been
treated with WT neuron-conditioned HBSS supplemented with
NMDA were found to be positive for ICAM-5, indicating that
the cells were capable of binding soluble fragments of ICAM-5
(Figure 2B). Microglia treated with ICAM-5 KO conditioned
HBSS supplemented with NMDA was negative for ICAM-5. The
experiments mentioned above provided evidence that ICAM-5
associated with β2 integrins on microglia. The co-localization
between ICAM-5 and β2 was more than moderate (Pearson’s
correlation coefficient 0.624, standard deviation 0.058, calculated
from cells represented in Figure 2Bh).
Soluble ICAM-5 bound to microglia and co-localized to
the β2 integrin chain (Figure 3A). To further study this, we
immunoprecipitated ICAM-5 from the adult mouse brain and
detected a significant amount of β2 integrin in the immune-
complex (Figure 3B). ICAM-5 also associates with β1 in vivo
(Ning et al., 2013). Neither β1 nor β2 integrins are exclusively
expressed by microglia in the brain, even though microglia are
the main cell type expressing β2. To investigate the role of β1
and β2 integrins in ICAM-5 binding in microglia, BV-2 cells
were treated with WT neuron-conditioned culture medium and
subjected to IP. A weak but significant association of ICAM-
5 with both β1 and β2 integrins could be seen (Figure 3C).
To avoid variance in protein expression levels, the CFE was
pooled for pre-clearing before incubation with the IP antibodies.
Furthermore, endogenous soluble ICAM-5 from neurons was
strongly bound by BV-2 cells, as seen by immunoprecipitating
ICAM-5 (Figure 3C). Lysates of unstimulated BV-2 cells did not
express ICAM-5 (data not shown) and microglia treated with
ICAM-5 KO conditioned medium were negative for ICAM-5,
which is in line with previous findings that ICAM-5 is neuron-
specific (Mitsui et al., 2005). The morphology of microglia treated
with WT or ICAM-5 KO neuron-conditioned HBSS with NMDA
for 2 h was also quantified but no significant differences were
found.
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FIGURE 2 | Endogenous neuronal ICAM-5 is bound by microglia in vitro. (A) ICAM-5 is released into the culture medium as is illustrated by the WB of WT
neuron-conditioned culture medium where cells were treated with HBSS with or without NMDA, with or without GM6001. (B) Microglia treated for 1 h with WT
neuron-conditioned HBSS with (Be–h) or without NMDA (Ba–d) were IF stained for integrin β2 (magenta, Ba,e), ICAM-5 (cyan, Bb,f) and F-actin (Bc,g). Bd,h are
merges of β2 and ICAM-5, scale bar = 50 µm. The strong increase in ICAM-5 staining in Bf indicates that ICAM-5 has been bound by microglia.
To further characterize the binding of ICAM-5 to microglia,
recombinant proteins were used. We used ICAM-5 coated beads
and allowed microglia to interact with these for 1 h prior to
fixation and IF staining. Figures 3Da,e show actin staining
(yellow), Figures 3Db,f show integrin β1 staining (cyan), and
Figures 3Dc,g show integrin β2 staining (magenta). To quantify
the involvement of integrins proved challenging, since integrins
are very dynamic and their recruitment around the beads
seems to be transient. During the 1 h experiment, most of the
bound beads were internalized completely. Only at the initial
contact site between the beads and the cells corresponding to
a small fraction of the beads, integrins were observed to form
clusters (Figure 3Dd, bead number 2). Beads that were already
completely internalized seemed to lose the integrin clustering
(Figure 3Dh, bead number 4). Beads not bound to the cells
were negative for β1 and β2 (Figure 3Dd, bead number 1) and
completely internalized beads can be seen as lack of staining,
especially clear by the actin staining (Figure 3De). Thus, integrins
seem to be involved in the capturing of the bead, with β2 binding
first, followed by β1.
Since glutamate-37 in ICAM-5 has been shown by
crystallography to be important for the binding to LFA-1
(Zhang et al., 2008), we wanted to explore this experimentally.
Beads were coated with D1-2 WT or D1-2 E37A mutant. ICAM-5
is known to bind both β1 and β2 integrins through the first two
domains (Tian et al., 2000a; Ning et al., 2013). Comparing D1-2
WT and E37A, the mutation significantly reduced the binding
capacity (∗∗P < 0.01, Figure 4A). As illustrated by the pull-down
assay in Figure 4B, we could further see that both WT and E37A
D1-2 were able to bind β1 integrins. However, only the WT could
pull down β2 from BV-2 lysates, but the β2 integrin is expressed
at low levels.
ICAM-5 Induces Clustering and Weak
Adhesion of Microglia
Now knowing that microglia bind ICAM-5, we were curious
to study the effect of this binding further. First, we wanted to
see if there were any gross differences in microglia morphology
and adhesiveness to ICAM-5 D1-2 and D1-9 as compared
to ICAM-1 in unstimulated cells. Using the static adhesion
assay, BV-2 cells and microglia were found to weakly adhere to
ICAM-5 D1-9-coated surfaces as compared to all other ligands
tested. After washing, most of the cells cultured for 24 h on
ICAM-5 D1-9 were removed (Figure 5Aa). The same effect
was observed with primary microglia (Figure 5Ab). The RTCA
iCELLigence instrument was used as an unbiased method to
measure cell spreading. Again, ICAM-5 D1-9 induced much less
spreading of microglia as compared to ICAM-1 (Figure 5Ba)
or ICAM-5 D1-2 WT or D1-2 E37A (Figure 5Bb). The effect
was rapid and was seen already 15 min after adding the cells
to the coated wells. The most prominent effect was observed
after 3 h. To explain the interesting effect of ICAM-5 D1-9,
Frontiers in Molecular Neuroscience | www.frontiersin.org 6 December 2017 | Volume 10 | Article 431
fnmol-10-00431 December 22, 2017 Time: 9:41 # 7
Paetau et al. Neuronal ICAM-5 Regulates Microglia Functions
FIGURE 3 | Endogenous neural ICAM-5 is bound by microglia in vitro and it
associates with integrins in vivo. (A) Primary microglia from WT mice were
treated with WT (Aa,b) or ICAM-5 KO (Ac,d) neuron-conditioned culture
medium and stained for ICAM-5 (Aa,c) and β2 (Ab,d). Scale bar = 10 µm.
ICAM-5 and β2 also associate in cortical homogenates of adult C57Bl/6j mice
when ICAM-5 is immunoprecipitated and the complex is blotted for β2 in B.
BV-2 cells as well bind ICAM-5, demonstrated by an IP of BV-2 cells treated
with WT neuron-conditioned medium in C. The IP antibodies are presented on
the top (IC5 = ICAM5) and the ICAM-5 antibody 246H is used as detection
antibody. Recombinant ICAM-5 D1-9 coupled to beads was bound by
microglia. (D) Microglia were allowed to interact with ICAM-5 D1-9 coated
beads and then stained for F-actin (yellow, Da,e), β1 integrins (cyan, Db,f), β2
integrins (magenta, Dc,g). In Dd,h, the figures a–c or e–g are merged and the
beads are illustrated by white circles that are numbered 1–4. Bead 1
represents a bead not bound by a cell, bead 2 is in the first stage of contact,
recruiting β2 integrins, bead 3 is captured by the cell, employing β1 integrins,
and bead 4 is completely internalized. Scale bar = 10 µm.
the experiment was repeated in cell culture plates and cells
were imaged after 24 h without washing (Figure 5C). At this
point, it was clear that on ICAM-5 D1-9 coated surface, BV-
2 cells formed clusters. These clusters did not adhere to the
substrate and are easily washed away. This assay was used to
screen for similar effects of other adhesion molecules (ICAM-
1, ICAM-2, VCAM-1, fibronectin and fibrinogen), but strong
FIGURE 4 | Glutamate-37 is important in ICAM-5 binding to β2 integrins.
(A) Microglia were allowed to interact with ICAM-5 D1-2 WT or D1-2 E37A
coated beads for 1 h and were then washed. Beads coated with D1-2 E37A
were significantly less bound as compared to the D1-2 WT (∗∗P < 0.01). The
D1-2 E37A protein was found to bind β1 but not β2 integrins in the pull-down
assay, shown in B. Separate pull-down eluates were blotted for β1 in the top
panel and β2 in the lower panel. The proteins used as baits are indicated on
top of the panels.
clustering was seen only for ICAM-5 D1-9. BV-2 spread poorly
on fibrinogen, and the cells appeared round and importantly
they did not form cell clusters. ICAM-1 function blocking
antibodies could not abolish the formation of cell clusters,
indicating that it is not involved in this process (data not
shown).
ICAM-5 Downregulates Phagocytosis in
Unchallenged Microglia
Phagocytosis is an essential function of microglia in both health
and disease. We saw a down-regulation of phagocytosis of small
latex beads when unstimulated microglia were treated with
soluble ICAM-5, as compared to soluble ICAM-1, human IgG or
non-treated cells (P< 0.001, Figures 6A,B). Soluble ICAM-5 D1-
9 could also inhibit BV-2 cell binding to coated iC3b as compared
to soluble IgG (P < 0.05, Figure 6C). Basal binding of BV-2 cells
to iC3b in the absence of any additional soluble proteins was
normalized to 100 and the presence of soluble ICAM-5 reduced
this binding by approximately 30% and by 40% as compared to
soluble IgG.
ICAM-5 Reduces TNF-α and IL-1β but
Promotes IL-10 Secretion from
LPS-Stimulated Microglia
Finally, we wanted to investigate the immunological implications
of ICAM-5 on microglia. Cytokine secretion into the culture
medium was measured by ELISA. Without LPS-stimulation,
cytokine production was negligible (data not shown), therefore
the cells were treated with LPS and the effect of ICAMs was
studied. The secretion of TNF-α was reduced by soluble ICAM-5
D1-9 (P = 0.03), however, ICAM-5 D1-2 showed no significant
effect (P = 0.79, Figure 7). ICAM-5 D1-2 significantly reduced
the secretion of IL-1β into the culture medium (P = 0.03),
whereas ICAM-1 had no effect. Interestingly, ICAM-5 D1-9 only
slightly reduced the secretion. However, the secretion of the anti-
inflammatory cytokine IL-10 was strongly increased when cells
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FIGURE 5 | The intercellular adhesion molecule-5 D1-9 coated surface is anti-adhesive and induced clustering of unstimulated microglia and BV-2 cells. Cells that
remain after washing when cultured for 24 h on ligand coated surface. (A) The number of cells per frame remaining after washing was quantified after staining with
DAPI. Aa represents BV-2 cells, while Ab is primary microglia (∗∗∗P < 0.001). The spreading of microglia on a ligand coated surface was also measured by
iCELLigence (Ba,b). The cell index was generated by the instrument as a value of impedance. The higher the number, the more spread the cells are. In C, BV-2 cells
were cultured for 24 h on various pre-coated surfaces as shown in the figure. The cells were imaged without washing and it is clear that cluster formation was
specifically induced by the ICAM-5 D1-9 coating. Scale bar = 100 µm.
were treated with soluble ICAM-5 D1-9. ICAM-5 D1-2 only
marginally reduced the secretion of CCL5.
DISCUSSION
We have now shown that microglia bind ICAM-5 in vitro.
This interaction is important to characterize since it is confined
to the brain and links neuronal functions to the immune
system.
In unchallenged microglia, soluble ICAM-5 impaired
phagocytosis of uncoated modified latex beads. Additionally,
adhesion to the complement factor iC3b was inhibited by
soluble ICAM-5. iC3b is an important mediator of phagocytosis
and C3 is involved in tagging synapses for pruning (Stevens
et al., 2007). It is possible that the soluble ICAM-5 released
from active synapses can reduce phagocytosis locally and
protect active synapses from being pruned. Proteins of the
FBS, such as vitronectin could play a role here (Furutani et al.,
2012).
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FIGURE 6 | The intercellular adhesion molecule-5 inhibits phagocytosis by unchallenged microglia or BV-2 cells. Microglia treated with soluble ICAM-5 D1-9 were
significantly less efficient in phagocytosing latex beads (Aa, quantified in B as number of beads per cell, ∗∗∗P < 0.001) as compared to cells treated with human IgG
(Ab), ICAM-1 (Ac) or PBS alone (Ad). Scale bar = 25 µm. Soluble ICAM-5 also inhibited BV-2 cell adhesion to iC3b coated surface (C) (∗P < 0.05). All microglia
were seeded on iC3b coated surface supplemented with soluble proteins as indicated. After 30 min the wells were washed and the remaining cells were quantified
by alkaline phosphatase assay. Cells not supplemented with any protein (first bar in the graph) were normalized to 100, representing the basal binding.
Comparing the effects of ICAM-1 versus ICAM-5 is
interesting. In the brain, ICAM-1 localizes mainly to glia,
endothelial and epithelial cells, while ICAM-5 is expressed by
telencephalic neurons (Tian et al., 2008). The expression of
ICAM-1 in the brain is regulated by cytokines and ICAM-1
is generally up-regulated under inflammatory conditions.
Leukocyte binding to ICAM-1 usually requires activation of the
cells. Both ICAM-1 and ICAM-5 can be solubilized and have as
such quite opposite effect on T-cells and macrophages. While
ICAM-1 is proinflammatory in macrophages (Schmal et al.,
1998), ICAM-5 was shown to be rather immune-suppressive
in T-cells (Tian et al., 2008). The M1/M2 paradigm has been
adopted from the peripheral immune system to categorize
microglia polarization, but it has proven to be insufficient in
explaining microglia inflammatory states. Many of the molecules
implicated in either M1 or M2 have different effects on neuronal
plasticity in the healthy brain (Donzis and Tronson, 2014).
For example, TNF-α is in a concentration dependent manner
important for learning and memory. We activated microglia
with LPS, which is a classical molecule rendering microglia the
M1 phenotype. TNF-α and IL-1β secretion from these cells
was decreased when the cells were co-stimulated with soluble
ICAM-5, while the anti-inflammatory IL-10 was upregulated.
ICAM-1 is known to induce TNF-α secretion in macrophages
(Schmal et al., 1998). In this case, however, all samples were
LPS-stimulated, which could mask the proinflammatory effect
of ICAM-1. Together, these data strongly suggest that ICAM-5
suppresses the M1 response or even tilt the phenotype toward
M2. IL-10 has previously been shown to reduce TNF-α secretion,
which could explain the observed reduction of TNF-α (Bolger
et al., 2002). The anti-inflammatory effect of ICAM-5 on
microglia indicates that it has an important neuroprotective
role.
The intercellular adhesion molecule-5 is solubilized under
several pathological conditions, such as encephalitis, and soluble
ICAM-5 is found in the serum of patients (Lindsberg et al.,
2002). ICAM-5 has a proven potential of modulating T-cell
responses and could function both locally in the brain and
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FIGURE 7 | Soluble ICAM-5 reduces TNF-α and IL-1β but induces IL-10 secretion under LPS challenge. ICAM-5 had a minor effect on CCL5 secretion. All microglia
were treated for 24 h with LPS and with soluble proteins as indicated. The cytokine production of cells in LPS only (first bar in each graph) was normalized to 100,
representing the induced production of each cytokine. The culture medium was analyzed for TNF-α, IL-1β, CCL5 and IL-10 using ELISA. TNF-α secretion was
significantly reduced when ICAM-5 D1-9 was present, as compared to controls [ICAM-1 (∗P < 0.05) or LPS only (∗∗P < 0.01)]. ICAM-5 D1-2 could also reduce
IL-1β secretion, as compared to ICAM-1 (∗P < 0.05) or LPS only (∗∗P < 0.01). The anti-inflammatory cytokine IL-10 was on the other hand upregulated by ICAM-5
D1-9, as compared to ICAM-1 (∗∗P < 0.01) or LPS only (∗∗∗P < 0.001).
systematically through the blood circulation. This poses an
interesting therapeutic potential for ICAM-5 that should be
explored in the future. ICAM-5 has been found to be internalized
from the membrane through endocytosis (Raemaekers et al.,
2012). The presence of ICAM-5 in extracellular vesicles has
not been studied, but it is more likely that ICAM-5 is
solubilized in free form at least in the NMDA-MMP-related
mechanism.
BV-2 cells formed large cell clusters when seeded on ICAM-
5-coated surfaces, as compared to all other proteins tested.
Neither primary microglia nor BV-2 cells were able to form firm
adhesion and spread on D1-9 coated surfaces. ICAM-5 seems to
be anti-adhesive; however, we cannot exclude that the ICAM-
5 ectodomain is not repulsive per se, but instead it induces a
signaling cascade that promotes surface expression or activation
of adhesive molecules on microglia. It seems possible that ICAM-
5 D3-9 could contain binding sites to a yet unknown receptor
that induces this signaling. It was generally difficult to get direct
and exclusive evidence of either β1 or β2 integrins binding
to ICAM-5 in vitro, further strengthening the possibility of
other receptors involved in the binding of ICAM-5 to microglia.
Soluble ICAM-5 was efficiently internalized by microglia in vitro
and endogenous ICAM-5 was not detected at least in BV-
2 cells. Previous studies have seen ICAM-5 immunoreactivity
in vivo in microglia (Kelly et al., 2014). However, it was
not defined whether this protein originated from endogenous
expression or if it was neuron derived and internalized through
scavenging.
In vivo studies have shown that microglia tends to make
direct contact with the spine heads, rather than the dendritic
shaft (Wake et al., 2009). ICAM-5 is abundantly expressed on
the dendritic shafts and filopodia, while it is expelled from the
mature spine heads (Matsuno et al., 2006). This repulsive effect
of the dendritic shafts could be conveyed by full-length ICAM-
5 that is abundant in the membrane. ICAM-5 may actually
function similarly to the developmental endothelial locus-1
(Del-1). Del-1 is a ligand for LFA-1 and strongly expressed in
the brain. By binding to this receptor, it reduces the LFA-1
binding to ICAM-1 and thereby limits adhesion of neutrophils
to endothelial cells (Choi et al., 2008). Del-1 has recently
been found to be anti-inflammatory in multiple sclerosis (Choi
et al., 2015), further strengthening the functional similarities
between these molecules. Our results are, however, contradictory
to the previous findings that microglia spread by addition
of ICAM-5 (Mizuno et al., 1999). We noted that microglia
are very sensitive to the presence of endotoxin in adhesion
studies and using the endotoxin removal column was essential.
Furthermore, the effect of ICAM-5 seems to be concentration
dependent and coated versus soluble administration can have
vastly different effects, demonstrating the versatility of this
molecule.
In the current study, ICAM-5-coated particles were bound by
microglia. Especially the beads coated with only the two most
rostral Ig-domains of ICAM-5, D1-2, were prominently bound
by microglia. This might be due to a different conformation
of ICAM-5. The avidity of the molecule can potentially be
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modulated by masking of binding sites or by homophilic binding
between molecules. When ICAM-5 is coupled to the beads,
the homophilic binding of D1-9 is presumably reduced on the
surface of the bead and more D1-2 sites are exposed. Coating
with only D1-2 further elevates the amount of binding sites.
D1-2 is also positively charged (Zhang et al., 2008; Recacha
et al., 2014), a trait that is known to facilitate internalization
of particles in phagocytic cells. When ICAM-5 D1-9 is coated
on a larger surface, it might be present in polymers due to
homophilic binding, which can have different binding and
signaling characteristics. We could additionally show, that the
functional binding of ICAM-5 to microglia was impaired when
glutamate-37 was mutated to alanine. The pull-down assay
revealed that only β2 binding is impaired, β1 less so. The
IF staining of β1 and β2 integrins in cells binding ICAM-5
coated beads provided clues that these integrins are recruited
at different stages of the capturing and internalization of cargo.
Since the bead binding was impaired in the case of the mutant,
it seems possible that the initial recruitment of β2 integrins
in the capturing of the particle is not essential in this type
of phagocytosis and additional receptors might play a role
here.
CONCLUSION
The intercellular adhesion molecule-5 is a unique adhesion
molecule in its binding capacity, flexibility and various potential
signaling abilities. As compared to the other members of the
ICAM family, ICAM-5 is the only one that is predominantly
expressed in the brain. It is possible, that ICAM-5 has different
effects on microglia, depending on whether the brain is under
development or immune challenge. Soluble and membrane-
bound forms of ICAM-5 seem to have different functions. ICAM-
5 is a versatile molecule and serves neurons differently during
development, promoting neurite sprouting, while in mature
neurons, it is a negative regulator of synaptic maturation. In
the aged brain, it might play a role in the pathophysiology
of Alzheimer’s disease (Annaert et al., 2001). This raises again
the interest to the role of microglia and the interaction with
ICAM-5.
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